Wednesday, July 8
Newsparlor
Sign in
Latest
Politics Lawsuit Accuses the US of Sharing Iranian Asylum Seekers' Details With IranScience Weight-Loss Drug Use Hits a Record High in the US, Survey FindsWorld China Sentences a Former Official to Death Over $325 Million in BribesSports Switzerland Beat Colombia on Penalties to Reach the World Cup QuarterfinalsSports Djokovic Survives a Five-Set Wimbledon Marathon to Reach the SemifinalsCulture Prince Harry Loses His Privacy Case Against the Daily Mail's PublisherWorld Landslide Buries Workers at a Tunnel Site in IndiaWorld US Strikes Southern Iran After Tanker Attacks in the Strait of HormuzPolitics Lawsuit Accuses the US of Sharing Iranian Asylum Seekers' Details With IranScience Weight-Loss Drug Use Hits a Record High in the US, Survey FindsWorld China Sentences a Former Official to Death Over $325 Million in BribesSports Switzerland Beat Colombia on Penalties to Reach the World Cup QuarterfinalsSports Djokovic Survives a Five-Set Wimbledon Marathon to Reach the SemifinalsCulture Prince Harry Loses His Privacy Case Against the Daily Mail's PublisherWorld Landslide Buries Workers at a Tunnel Site in IndiaWorld US Strikes Southern Iran After Tanker Attacks in the Strait of Hormuz

Topic: diabetes

An Ozempic injection pen (file image)
Science
Wednesday, 7/8, 01:26 AM

Weight-Loss Drug Use Hits a Record High in the US, Survey Finds

  • About one in eight American adults now say they are taking a GLP-1 drug such as Ozempic or Wegovy, a record share, according to new polling.
  • Cheaper compounded versions and online prescribing have widened access, even as cost, side effects and safety questions remain.

diabetes — news and stories on this topic

This page collects all of Newsparlor's coverage of diabetes. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse world news, business news, sport and politics, or head back to the front page for the day's top stories.